Physician profile
Thomas Chow
NPI 1205017696
$10,533.45
in general payments reported to CMS, 2019-2025
26 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $948 · 2021: $7,412 · 2022: $179 · 2023: $1,061 · 2024: $286 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $788.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,196.97 | 2020-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $264.21 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $206.99 | 2023-2025 | Irrisept |
| Smith+Nephew, INC. | $127.96 | 2019-2025 | Renasys Go V2 Home, Pico |
| Conmed Corporation | $113.90 | 2025 | Airseal, Conmed Trocars |
| Cardiovascular Systems INC. | $72.44 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $66.12 | 2021 | |
| Ethicon US, LLC | $61.16 | 2019-2020 | |
| Heron Therapeutics, INC. | $60.96 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $51.58 | 2019-2022 | |
| Abbvie INC. | $36.98 | 2021-2022 | |
| Convatec INC. | $29.99 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $28.24 | 2023 | Keytruda, Lynparza |
| Baudax Bio INC. | $27.19 | 2020 | |
| Davol INC. | $27.15 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.38 | 2020 | |
| Kci USA, INC. | $17.44 | 2021 | |
| Acera Surgical, INC. | $17.36 | 2019 | |
| Baxter Healthcare | $17.12 | 2020 | |
| Cook Medical LLC | $14.26 | 2019 | |
| Bioventus LLC | $13.82 | 2022 | |
| Teleflex LLC | $13.41 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.36 | 2022 | |
| W. L. Gore & Associates, INC. | $11.98 | 2019 | |
| Medela LLC | $11.91 | 2020 | |
| Portola Pharmaceuticals, LLC | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.